Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1990 1
1991 2
1993 1
1996 2
2001 3
2002 2
2003 9
2004 1
2005 14
2006 10
2007 4
2008 4
2009 9
2010 6
2011 7
2012 3
2013 3
2014 7
2015 11
2016 6
2017 6
2018 2
2019 7
2020 8
2021 4
2022 7
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Cancer immunotherapy.
Baxevanis CN, Perez SA, Papamichail M. Baxevanis CN, et al. Among authors: perez sa. Crit Rev Clin Lab Sci. 2009;46(4):167-89. doi: 10.1080/10408360902937809. Crit Rev Clin Lab Sci. 2009. PMID: 19650714 Free article. Review.
HER-2/neu as a target for cancer vaccines.
Baxevanis CN, Voutsas IF, Gritzapis AD, Perez SA, Papamichail M. Baxevanis CN, et al. Among authors: perez sa. Immunotherapy. 2010 Mar;2(2):213-26. doi: 10.2217/imt.09.89. Immunotherapy. 2010. PMID: 20635929 Review.
AE37: a novel T-cell-eliciting vaccine for breast cancer.
Sears AK, Perez SA, Clifton GT, Benavides LC, Gates JD, Clive KS, Holmes JP, Shumway NM, Van Echo DC, Carmichael MG, Ponniah S, Baxevanis CN, Mittendorf EA, Papamichail M, Peoples GE. Sears AK, et al. Among authors: perez sa. Expert Opin Biol Ther. 2011 Nov;11(11):1543-50. doi: 10.1517/14712598.2011.616889. Epub 2011 Sep 6. Expert Opin Biol Ther. 2011. PMID: 21895539 Review.
Endogenous immunity at the forefront of tumor dormancy.
Baxevanis CN, Perez SA. Baxevanis CN, et al. Among authors: perez sa. Future Sci OA. 2015 Nov 1;1(3):FSO13. doi: 10.4155/fso.15.11. eCollection 2015 Nov. Future Sci OA. 2015. PMID: 28031888 Free PMC article. No abstract available.
A new era in anticancer peptide vaccines.
Perez SA, von Hofe E, Kallinteris NL, Gritzapis AD, Peoples GE, Papamichail M, Baxevanis CN. Perez SA, et al. Cancer. 2010 May 1;116(9):2071-80. doi: 10.1002/cncr.24988. Cancer. 2010. PMID: 20187092 Free article. Review.
Immunogenic HER-2/neu peptides as tumor vaccines.
Baxevanis CN, Sotiriadou NN, Gritzapis AD, Sotiropoulou PA, Perez SA, Cacoullos NT, Papamichail M. Baxevanis CN, et al. Among authors: perez sa. Cancer Immunol Immunother. 2006 Jan;55(1):85-95. doi: 10.1007/s00262-005-0692-3. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15948002 Free PMC article. Review.
Prostate cancer vaccines: the long road to clinical application.
Baxevanis CN, Papamichail M, Perez SA. Baxevanis CN, et al. Among authors: perez sa. Cancer Immunol Immunother. 2015 Apr;64(4):401-8. doi: 10.1007/s00262-015-1667-7. Epub 2015 Feb 19. Cancer Immunol Immunother. 2015. PMID: 25690791 Free PMC article. Review.
124 results